Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

Technology appraisal guidance
Reference number: TA673
Published: 17 February 2021

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 141 KB)

Published:

17 February 2021
Register of interests (PDF 162 KB)

Published:

26 February 2021

Invitation to participate

Final scope (PDF 201 KB)

Published:

11 March 2020
Final stakeholder list (PDF 186 KB)

Published:

11 March 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 247 KB)

Published:

20 April 2020
Equality impact assessment (Scoping) (PDF 124 KB)

Published:

20 April 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 271 KB)

Published:

15 January 2021
Final appraisal document - Managed Access Agreement (PDF 387 KB)

Published:

15 January 2021
Committee papers (PDF 6.58 MB)

Published:

15 January 2021
Public committee slides (PDF 1.38 MB)

Published:

15 January 2021

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 211 KB)

Published:

19 November 2019
Draft matrix post referral (PDF 187 KB)

Published:

19 November 2019